Abdominal Cancer
55
6
8
35
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.6%
2 terminated out of 55 trials
94.6%
+8.1% vs benchmark
13%
7 trials in Phase 3/4
17%
6 of 35 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 35 completed trials
Clinical Trials (55)
Evaluation of On-Couch CBCT Image Quality
The Effect of Patient Position Changes on Advanced Cardiac Indices in Cancer Surgery
The PIPAC-OPC7 Study: The Use of PET/CT Scans as a Method of Evaluation in Patients Treated With PIPAC, a Pilot Study.
Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining)
Preoperative Smoking Cessation in Patients Undergoing Surgery
Ablative Stereotactic MR-Guided Adaptive Reirradiation
Effectiveness of Pain Management Interventions in Patients With Abdominal and Pelvic Cancer
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy
Vessel- and Bone-based Ultrasound Registration
Magnetic Resonance Imaging (MRI) Guided Stereotactic Adaptive Radiotherapy for Targeting Abdominal Cancer
A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION)
A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System
Neurolytic Block Techniques In Abdominal Visceral Cancer Pain
Characterizing Postoperative T and B Cell Dysfunction in Cancer Surgery Patients, Using COVID-19 as a Model Antigen
Dosage of Epidural Morphine in Elderly Patients
Reconstruction in Extended MArgin Cancer Surgery
Feasibility Study of Intra-Tumoral Lipopolysaccharide Immunotherapy for Intra-Abdominal
VisionRT-based Deep Inspiration Breath-hold (DIBH) Respiratory Motion Management Strategy, A Pilot Study for Thoracic and Abdominal Tumors
Effect of Addition of Dexmedetomidine or Ketamine to Intravenous Infusion of Lidocaine on Proinflammatory Cytokines in Pelvi-abdominal Cancer Surgeries.